The NPRL3 gene helps cells sense when nutrients are low and turn down a growth signal called mTOR, which helps keep cell activity in balance. This gene plays an important role in the brain, where controlled growth signals support normal development and electrical activity. If you carry a disease causing variant in the NPRL3 gene, that braking system may work less well, and some people develop focal epilepsy, sometimes with differences in how part of the brain formed. Effects vary, so seizures and related symptoms can be mild in some people and more noticeable in others.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Others mainly help direct when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. If you want to go deeper into this topic, you can find more in the LearnHub.
Overview
NPRL3Gene function
What if the gene works
The NPRL3 gene helps cells sense nutrient levels and slow growth signals when nutrients are low. This supports balanced cell growth, energy use, and recycling of worn cell parts.
Risk
What if the gene does not work
Variants in the NPRL3 gene are linked to focal epilepsy, with seizures starting in childhood or later. Effects can range from milder epilepsy to developmental and epileptic encephalopathy, depending on how much gene function is altered.
Treatment
What does that mean for your treatment
For a pathogenic or loss of function variant in the NPRL3 gene, no treatment or drug choice tailored to NPRL3 is currently established in clinical guidelines. Care usually follows standard management for the person’s symptoms, while mTOR pathway inhibitors such as everolimus are being studied for some GATOR1 related epilepsies linked to the NPRL3 gene.
Conditions associated with NPRL3
Gene function
What if the gene works
Your cells use the NPRL3 gene to match growth and energy use to the nutrients around them. This helps everyday cell work stay balanced instead of running at full speed all the time. Understanding how the NPRL3 gene helps control cell growth makes its role in the body easier to picture.
NPRL3 helps cells respond to amino acid levels, which are the building blocks of protein. When supplies drop, it helps pass along that message so cell activity can adjust.
As part of a three protein team, NPRL3 helps put a brake on mTORC1 (a major cell growth signal). This keeps growth and protein production aligned with the cell's available resources.
By lowering growth signals during lean times, NPRL3 supports autophagy (the cell's recycling process). This helps cells reuse materials and maintain a steadier internal balance.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many do not produce any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NPRL3 gene often weaken or cut short the NPRL3 protein, which can leave mTORC1, a cell growth signaling pathway, too active inside cells. This helps explain how NPRL3 gene variants affect cell signaling in the brain. Some variants still allow partial protein function, while more disruptive variants may stop it almost completely and are more often linked to earlier seizures or broader effects on brain development.
How variants are linked to conditions
Pathogenic variants in the NPRL3 gene cause a spectrum of epilepsy conditions, most often focal epilepsy, including familial focal epilepsy with variable foci. Some people also have developmental delay or a brain malformation seen on MRI, such as focal cortical dysplasia. Seizure type, age at onset, and overall impact can vary widely from one person to another.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural differences between people. For many genes, a variant associated with a condition points to a possible link rather than a clear diagnosis, particularly when several genes and environmental influences contribute. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NPRL3, the genetic change itself appears to be the main driver of risk, but not everyone with a change will develop symptoms. Seizure chances may also be influenced by other genes and common seizure triggers such as poor sleep, illness, alcohol, or severe stress, though gene-specific evidence is still limited.
Inheritance of NPRL3 variants
For NPRL3-related epilepsy, variants in the NPRL3 gene are usually inherited in an autosomal dominant pattern. This means a parent carrying a disease-causing variant has a 50% chance of passing it on to each child. Understanding how NPRL3 gene variants are inherited also includes knowing that not everyone who inherits the variant will have the same symptoms, and some may never develop seizures. A variant can be passed from a mother or father to a son or daughter.
What does my NPRL3 result mean for my family?
For families, an NPRL3 result is most often relevant because NPRL3-related epilepsy can run in families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. Some relatives may have seizures, while others may carry the variant with milder symptoms or no obvious symptoms at all. In some families, the variant is new in one person, so it is not always inherited from a parent.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to the NPRL3 gene, doctors use genetic testing for NPRL3 variants on a blood or saliva sample. A lab reads the DNA sequence and checks for variants. Results may show a disease causing variant, a benign variant, or an uncertain finding that needs clinical interpretation.
When should I consider getting a genetic test?
If you or close relatives have epilepsy—especially seizures that seem to start in one part of the brain, began in childhood, or run in the family—testing the NPRL3 gene may be worth considering. It can sometimes help confirm an inherited cause, especially when a brain scan shows a small area that did not develop in the usual way.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is common and can help explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way a person responds to medicines. By looking at links between genes and medications, it helps explain why the same treatment may work differently from one person to another. For many drugs, genes can influence how strongly a medicine works or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. If you want to read more about this topic, more information is available in the LearnHub.
Drugs influenced by the NPRL3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or predicting medicine response, so questions about side effects, treatment changes, or drug safety are best discussed with your doctor.
History
The NPRL3 gene entered medical genetics through two different research paths. In the late 1990s and early 2000s, scientists identified it as the human counterpart of a yeast gene involved in basic cell growth pathways. Building on this early work, researchers also found that parts of the NPRL3 gene region contain important control elements for the nearby alpha globin genes, which made it notable in studies of inherited anemia. This helped show that changes outside a protein coding region can still have major health effects. Later, rare variants in the NPRL3 gene were linked to some families with focal epilepsy, expanding its clinical importance. Over time, scientists’ understanding of the gene’s place in human disease became much broader.